Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H11N4O2S.Na |
Molecular Weight | 286.285 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CC1=CC=NC([N-]S(=O)(=O)C2=CC=C(N)C=C2)=N1
InChI
InChIKey=BSFJGCCAXDCMOX-UHFFFAOYSA-N
InChI=1S/C11H11N4O2S.Na/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10;/h2-7H,12H2,1H3;/q-1;+1
Sulfamerazine is a sulfonamide antibiotic, which acts by inhibiting folic acid synthesis in bacterias. The primary target of sulfamerazine is believed to be dihydropteroate synthetase. Sulfamerazine (in comination with Sulfadiazine and Sulfamethazine) was used in the US under different names, including the earliest brand of Neotrizine. Nowdays, the drugs containing sulfamerazine are no longer available for use in humans in the US, however, they may be prescribed for veterinary purposes.
Originator
Approval Year
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
37.61 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8486092/ |
60 mg/kg single, intravenous dose: 60 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
SULFAMERAZINE plasma | Bos taurus population: HEALTHY age: ADOLESCENT sex: UNKNOWN food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
2023.4 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8486092/ |
60 mg/kg single, intravenous dose: 60 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
SULFAMERAZINE plasma | Bos taurus population: HEALTHY age: ADOLESCENT sex: UNKNOWN food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
7.08 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/8486092/ |
60 mg/kg single, intravenous dose: 60 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
SULFAMERAZINE plasma | Bos taurus population: HEALTHY age: ADOLESCENT sex: UNKNOWN food status: UNKNOWN |
Doses
Dose | Population | Adverse events |
---|---|---|
6 g multiple, oral (starting) Highest studied dose Dose: 6 g Route: oral Route: multiple Dose: 6 g Sources: |
unhealthy n = 35 Health Status: unhealthy Population Size: 35 Sources: |
Other AEs: Renal calculus, Rash... Other AEs: Renal calculus (4 patients) Sources: Rash (2 patients) Conjunctivitis (2 patients) Fever (2 patients) |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Conjunctivitis | 2 patients | 6 g multiple, oral (starting) Highest studied dose Dose: 6 g Route: oral Route: multiple Dose: 6 g Sources: |
unhealthy n = 35 Health Status: unhealthy Population Size: 35 Sources: |
Fever | 2 patients | 6 g multiple, oral (starting) Highest studied dose Dose: 6 g Route: oral Route: multiple Dose: 6 g Sources: |
unhealthy n = 35 Health Status: unhealthy Population Size: 35 Sources: |
Rash | 2 patients | 6 g multiple, oral (starting) Highest studied dose Dose: 6 g Route: oral Route: multiple Dose: 6 g Sources: |
unhealthy n = 35 Health Status: unhealthy Population Size: 35 Sources: |
Renal calculus | 4 patients | 6 g multiple, oral (starting) Highest studied dose Dose: 6 g Route: oral Route: multiple Dose: 6 g Sources: |
unhealthy n = 35 Health Status: unhealthy Population Size: 35 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Determination of selected sulfonamide antibiotics and trimethoprim in manure by electrospray and atmospheric pressure chemical ionization tandem mass spectrometry. | 2002 |
|
Synthesis of (+)-8-deoxyvernolepin and its 11,13-dihydroderivative. A novel reaction initiated by sulfene elimination leads to the 2-Oxa-cis-decalin skeleton. | 2002 Aug 9 |
|
Iminodibenzyl as a novel coupling agent for the spectrophotometric determination of sulfonamide derivatives. | 2002 Mar |
|
Stability of sulfonamides, nitrofurans, and chloramphenicol residues in preserved raw milk samples measured by liquid chromatography. | 2002 Nov-Dec |
|
Two new cinnamic acid esters from Marine brown alga Spatoglossum variabile. | 2002 Sep |
|
In vitro susceptibility of Ornithobacterium rhinotracheale to several antimicrobial drugs. | 2003 Apr-Jun |
|
3-Aminophenol as a novel coupling agent for the spectrophotometric determination of sulfonamide derivatives. | 2003 Dec |
|
Liquid chromatography-fluorescence detection for simultaneous analysis of sulfonamide residues in honey. | 2003 Jun |
|
Survey of residual tetracycline antibiotics and sulfa drugs in kidneys of diseased animals in the Aichi Prefecture, Japan (1995-1999). | 2003 May-Jun |
|
Validation of a confirmatory method for the determination of sulphonamides in muscle according to the European Union regulation 2002/657/EC. | 2004 Apr 2 |
|
Linkage isomerism, structure, and reactivity studies of sulfenamide complexes of cobalt(III). | 2004 Aug 23 |
|
[Hygienic forecasting and toxicologic evaluation of potential danger caused by new sulphenamide vulcanization accelerators]. | 2005 |
|
[Qualification and quantification of 10 sulfonamides in animal feedstuff by high performance liquid chromatography-electrospray tandem mass spectrometry]. | 2005 Jul |
|
Triplet-sensitized photodegradation of sulfa drugs containing six-membered heterocyclic groups: identification of an SO2 extrusion photoproduct. | 2005 May 15 |
|
A study of sulfamerazine single crystals using atomic force microscopy, transmission light microscopy, and Raman spectroscopy. | 2005 Sep |
|
Dispersive solid-phase extraction for the determination of sulfonamides in chicken muscle by liquid chromatography. | 2005 Sep 16 |
|
Direct organocatalytic asymmetric alpha-sulfenylation of activated C-H bonds in lactones, lactams, and beta-dicarbonyl compounds. | 2005 Sep 19 |
|
Simultaneous determination of 16 sulfonamides in honey by liquid chromatography/tandem mass spectrometry. | 2005 Sep-Oct |
|
Synthesis, characterization, and biotoxicity of N N donor sulphonamide imine silicon(IV) complexes. | 2006 |
|
A simplified LC-DAD method with an RP-C12 column for routine monitoring of three sulfonamides in edible calf and pig tissue. | 2006 Aug |
|
Rate constants for anilidyl radical cyclization reactions. | 2006 Jan 20 |
|
Oxidation of sulfonamides, macrolides, and carbadox with free chlorine and monochloramine. | 2006 Jul |
|
Determination of sulfonamide antibiotics in wastewater: a comparison of solid phase microextraction and solid phase extraction methods. | 2006 Oct 27 |
|
Determination of sulfonamides in selected Malaysian swine wastewater by high-performance liquid chromatography. | 2006 Sep 15 |
|
Catalytic enantio- and diastereoselective formation of beta-sultones: ring-strained precursors for enantioenriched beta-hydroxysulfonyl derivatives. | 2007 |
|
Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents. | 2007 Apr 15 |
|
Preparation, characterization and in vivo conversion of new water-soluble sulfenamide prodrugs of carbamazepine. | 2007 Dec 1 |
|
Reactions of sulfenic acid with 2-mercaptoethanol: a mechanism for the inhibition of gastric (H+-K+)-adenosine triphosphate by omeprazole. | 2007 Jan |
|
Toxoplasma gondii: cross-immunity against the enteric cycle. | 2007 Jan |
|
Simultaneous determination of 17 sulfonamides and the potentiators ormetoprim and trimethoprim in salmon muscle by liquid chromatography with tandem mass spectrometry detection. | 2007 Jan-Feb |
|
[Determination of 12 sulfonamides in cosmetics by ultra performance liquid chromatography]. | 2007 Mar |
|
Determination of 10 sulfonamide residues in meat samples by liquid chromatography with ultraviolet detection. | 2007 Mar-Apr |
|
Analytical methods for multiresidue determination of sulfonamides and trimethoprim in meat and ground water samples by CE-MS and CE-MS/MS. | 2007 Nov |
|
Determination of sulphonamides in animal tissues by high performance liquid chromatography with pre-column derivatization of 9-fluorenylmethyl chloroformate. | 2007 Nov |
|
Synthesis and insecticidal activities of novel N-sulfenyl-N'-tert-butyl-N,N'-diacylhydrazines. 1. N-alkoxysulfenate derivatives. | 2007 Nov 14 |
|
Validation of a Biacore method for screening eight sulfonamides in milk and porcine muscle tissues according to European decision 2002/657/EC. | 2007 Nov-Dec |
|
[Simultaneous determination of seven sulfonamides and metronidazole and chloramphenicol in cosmetics by high performance liquid chromatography]. | 2007 Sep |
|
Free-radical-induced oxidative and reductive degradation of sulfa drugs in water: absolute kinetics and efficiencies of hydroxyl radical and hydrated electron reactions. | 2007 Sep 20 |
|
[Development of a fluorescence polarization immunoassay for sulfamerazine]. | 2008 Jul |
|
Analysis of sulfamerazine in pond water and several fishes by high-performance liquid chromatography using molecularly imprinted solid-phase extraction. | 2008 Jul |
|
Intramolecular nonbonded S...N interaction in rabeprazole. | 2008 Jun |
|
Application of liquid-liquid-liquid microextraction and high-performance liquid-chromatography for the determination of sulfonamides in water. | 2008 Mar 31 |
|
Simultaneous determination of sulphamerazine, sulphamethazine and sulphadiazine in honey and chicken muscle by a new monoclonal antibody-based fluorescence polarisation immunoassay. | 2008 May |
|
Purification of nine sulfonamides from chicken tissues by immunoaffinity chromatography using two monoclonal antibodies. | 2008 Nov-Dec |
|
Theoretical 14N nuclear quadrupole resonance parameters for sulfa drugs: sulfamerazine and sulfathiazole. | 2008 Oct |
|
Occurrence and elimination of antibiotics at four sewage treatment plants in Japan and their effects on bacterial ammonia oxidation. | 2009 |
|
Degradation and elimination of various sulfonamides during anaerobic fermentation: a promising step on the way to sustainable pharmacy? | 2009 Apr 1 |
|
Development and validation of a confirmatory method for the determination of sulphonamides in milk by liquid chromatography with diode array detection. | 2009 Apr 1 |
|
The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption. | 2009 Jul 23 |
|
A confirmatory method for the simultaneous extraction, separation, identification and quantification of Tetracycline, Sulphonamide, Trimethoprim and Dapsone residues in muscle by ultra-high-performance liquid chromatography-tandem mass spectrometry according to Commission Decision 2002/657/EC. | 2009 Nov 13 |
Patents
Sample Use Guides
Adults: 2 tablets (each tablets contains 167 mg Sulfamerazine, 167 mg Sulfadiazine and 167 mg Sulfamethazine) every 12 hours or an initial dose of 4 tablets followed by 2 tablets every 6 hours.
Route of Administration:
Oral
Sulfamerazine MIC50 values were >50 ug/ml (B. fragilis group), 6.4 ug/ml (Bacteroides sp.), 3.2 ug/ml (Fusobacterium sp.), 1.6 ug/ml (Clostridium sp.), 12.5 ug/ml (Anaerobic cocci) and 6.4 ug/ml (Non-spore-forming, gram-positive rods).
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29739
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
JOV4UJY07O
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
100000083270
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL438
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
204-851-0
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
DBSALT002208
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
JOV4UJY07O
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
SUB10709MIG
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
127-58-2
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
DTXSID1051644
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
m10315
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
15899899
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
C80794
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
226823
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | |||
|
1306109
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY | RxNorm | ||
|
425
Created by
admin on Fri Dec 15 15:06:57 GMT 2023 , Edited by admin on Fri Dec 15 15:06:57 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD